| FDA Issues Safety Announcement: Proton Pump Inhibitors (PPIs) Possibly Associated with Clostridum Difficile-Associated Diarrhea (CDAD) |
|
2012-02-08 |
FDA |
| Teva Pharmaceuticals USA, Inc Recalls Select Lots of Tetracycline Capsules 500 mg |
|
2012-02-02 |
FDA |
| Sanofi-aventis US, Inc. Recalls Several Lots of Lantus |
|
2012-02-02 |
FDA |
| Glenmark Generics Inc. Recalls Single Lot of Glenmark Clotrimazole Cream |
|
2012-02-02 |
FDA |
| Paddock Laboratories, Inc. Recalls Select Lots of Ciclopirox Gel 0.77% |
|
2012-02-02 |
FDA |
| Warner Chilcott Company Recalls Several Lots of Ovcon 50 (Norethindrone and ethinyl estradiol ) Tablets, 1 mg/50 mcg |
|
2012-02-02 |
FDA |
| Taro Pharmaceuticals USA, Inc. Recalls Several Lots of Fluocinonide, Ointment USP, 0.05% |
|
2012-02-02 |
FDA |
| Sandoz Inc. Recalls Single Lot of Fluoxetine Capsules 10 mg |
|
2012-02-02 |
FDA |
| Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Tablet Mix-Up |
|
2012-02-01 |
Manufacturer |
| reanda (bendamustine HCL) Recall - Particles Found in Vial |
|
2012-01-30 |
FDA |
| FDA Makes Changes to Risk Evaluation and Mitigation Strategies (REMS) Program for Nplate (Romiplostim) and Promacta (Eltrombopag) |
|
2012-01-26 |
FDA |
| FDA Announces New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) Associated with Tysabri (Natalizumab) |
|
2012-01-24 |
FDA |
| Rexall, Inc Issues Allergy Alert and Recall of Single Lot of Calcium 1200mg plus Vitamin D 1000 IU Softgels |
|
2012-01-18 |
FDA |
| New Study Raises Concerns about Daily Aspirin Use in People Without a History of Heart Disease |
|
2012-01-18 |
MediGuard CRT |
| New Boxed Warning for Progressive Multifocal Leukoencephalopathy (PML) and Contraindication for Adcetris (brentuximab vedotin) |
|
2012-01-16 |
FDA |
| New Study Study Finds Small Increased Risk of Heart Attack in Patients Treated with Pradaxa |
|
2012-01-13 |
MediGuard CRT |
| Possible Supply Shortage and Rare Tablet Mix-up For Opioid Pain Medications from Endo Pharmaceuticals |
|
2012-01-09 |
FDA |
| Novartis Provides Important Information about Tekturna and Aliskiren-Based Products |
|
2012-01-09 |
Manufacturer |
| Novartis Consumer Health Inc. Issues Voluntary Recall Of Certain Excedrin, Bufferin, and Gas-X Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps |
|
2012-01-09 |
FDA |
| Teva Pharmaceuticals USA Recalls Single Lot of Hydralazine Hydrochloride Tablets, USP, 25 mg |
|
2012-01-04 |
FDA |
Ask Us
